Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone for non-motor symptoms in Parkinson’s disease (open-label extension)
2017-004253-16Phase 3Completed
- Sponsor
- Medical University of Innsbruck, University Clinic for Neurology
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of nabilone in Parkinson's disease (PD), sponsored by Medical University of Innsbruck, University Clinic for Neurology. Started Feb 2018; status: completed.
02
Drugs
nabilone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2017-004253-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004253-16.